Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA
A patient with CKD5D receiving haemodialysis treated with denosumab
CKD-MBD Working Group
Speakers
Maria Jesus Lloret, Spain
Juan Miguel Diaz-Tocados, Spain
Panellists
Marie-Helene Lafage-Proust, France
Bente Langdahl, Denmark
Moderator
Syazrah Salam, United Kingdom